Striatal expression of glutamic acid decarboxylase gene in Alzheimer's disease.
To examine potential alteration of GABAergic striatal neurons in Alzheimer's disease, we used quantitative in situ hybridization to analyze the messenger RNA coding for Mr 67,000 glutamic acid decarboxylase (GAD67 mRNA) in the striatum of five patients with Alzheimer's disease (AD) and nine matched control subjects. We found a 51-57% increase in the optical density of hybridization signal in the caudate nucleus and putamen, corresponding to a 30-42% increase in the number of neurons expressing a detectable amount of GAD67 mRNA. By contrast, no alteration was observed in the ventral striatum. The expression of GAD67 mRNA per neuron was similar in AD and control subjects both in the dorsal and ventral striatum. Taken together, our data indicate that, in AD, GABAergic neurotransmission is increased in the dorsal striatum but not in the ventral striatum. We suggest that this increased GABAergic neurotransmission may explain extrapyramidal signs often observed in AD.
INSERM U289, Hôpital de la Salpêtrière, Paris, France.
F
F
Boissière
B
B
Faucheux
C
C
Duyckaerts
J J
JJ
Hauw
Y
Y
Agid
E C
EC
Hirsch
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000235:genetics* / Q000378:metabolism*; D003342:Corpus Striatum / Q000201:enzymology*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D005968:Glutamate Decarboxylase / Q000235:genetics*; D006801:Humans; D017403:In Situ Hybridization; D008297:Male; D012333:RNA, Messenger / Q000032:analysis
D012333:RNA, Messenger; D005968:Glutamate Decarboxylase